HOME >> BIOLOGY >> NEWS
Gene profiling predicts resistance to breast cancer drug Herceptin

PHILADELPHIA -- Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.

In the February 15 issue of Clinical Cancer Research, the researchers found that HER2-positive tumors that did not respond to Herceptin expressed certain basal markers, growth factors and growth factor receptors. One of these, insulin-growth factor receptor 1(IGF-1R), was associated with a Herceptin response rate that was half that of tumors that did not express IGF-1R.

They also discovered that resistant tumors continue to over-express the HER2 growth factor protein -- an important finding given that many scientists had thought that loss of HER2 was likely responsible for Herceptin resistance.

"Herceptin has revolutionized the care of HER2-positive breast cancer for many patients, but unfortunately, not for some. This work demonstrates that digging deeper into the molecular subtypes of these tumors helps us understand why some tumors are resistant and may point to ways to remedy that," said the studys lead author, Lyndsay Harris, M.D., associate professor and Director of the Breast Cancer Disease Unit at Yale University Medical Center.

If additional studies validate these findings, it may be possible to select those patients that will be resistant to Herceptin and treat them with additional drugs to restore Herceptin sensitivity, according to Harris. "Our goal is to see what the tumor tells us before any treatment starts and tailor therapy accordingly," she said.

To determine Herceptin sensitivity, investigators took a small tumor biopsy from 48 patients with newly diagnosed and operable stage II/III breast cancer. They examined the biopsy t
'"/>

Contact: Greg Lester
lester@aacr.org
267-646-0554
American Association for Cancer Research
20-Feb-2007


Page: 1 2 3

Related biology news :

1. Prediction of graft-versus-host disease by gene-expression profiling of donors and more
2. Three new lung tumor subtypes identified in DNA profiling study
3. Preterm birth risk quickly and accurately detected with proteomic profiling
4. miRNA profiling
5. Gene expression profiling aids in ovarian cancer prognosis
6. Powerful toolkit developed for functional profiling of yeast genes
7. Gene predicts better outcome as cortex normalizes in teens with ADHD
8. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
9. Major study predicts grim future for Europes seas
10. FDG-PET imaging clearly predicts lung cancer patients response to chemotherapy
11. NASA predicts nongreen plants on other planets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... August 05, 2019 , ... ... to announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M ... the Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the ...
(Date:8/1/2019)... ... August 01, 2019 , ... The GENSPEED platform is a compact, ... It is fully developed with over 100 units deployed in the field for multiple ... use, our collaboration with axiVEND will give us a foothold in the USA to ...
(Date:8/1/2019)... ... July 31, 2019 , ... Advancements with ... local listings for more information. , Factor Bioscience Inc. (Factor) is pioneering nucleic-acid ... and age-related diseases. This segment of Advancements will explore how Factor Bioscience is ...
Breaking Biology News(10 mins):
(Date:6/12/2019)... N.J. (PRWEB) , ... June 12, 2019 , ... ... custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and ... Shanghai Zillion has been signed. The agreement will grant exclusive rights for Zillion ...
(Date:6/11/2019)... REDWOOD CITY, Calif. (PRWEB) , ... June 10, ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to ... addition of physics-related content to DeepDyve’s continually expanding library of more than 20 ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today in ... are able to incorporate into human CD34+ cells, modifying their gene expression and ... increased the cells’ ability to lodge into bone marrow. This research performed by ...
(Date:5/31/2019)... (PRWEB) , ... May 29, ... ... our patent applications from the USPTO providing proprietary interest to our methodology, ... FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our ...
Breaking Biology Technology:
Cached News: